+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Melanoma Therapeutics - Market Analysis, Trends, and Forecasts

  • ID: 1227794
  • Report
  • 252 Pages
  • Global Industry Analysts, Inc
1 of 3

FEATURED COMPANIES

  • Amgen
  • Astrazeneca Plc
  • Eisai Co.
  • F. Hoffmann-La Roche Ag
  • Merck & Co., Inc.
  • Novartis International Ag
  • MORE
The Melanoma Therapeutics market worldwide is projected to grow by US$3.9 Billion, driven by a compounded growth of 12.4%. Cutaneous Melanoma, one of the segments analyzed and sized in this study, displays the potential to grow at over 12.2%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$3.1 Billion by the year 2025, Cutaneous Melanoma will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 11% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$152.5 Million to the region's size and clout in the next 5 to 6 years. Over US$127.5 Million worth of projected demand in the region will come from the rest of the European markets. In Japan, Cutaneous Melanoma will reach a market size of US$158.4 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 15.8% over the next couple of years and add approximately US$924 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders.

Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include:
  • Amgen, Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Eisai Co., Ltd.
  • F. Hoffmann-La Roche AG
  • Iovance Biotherapeutics, Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Pfizer, Inc.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Amgen
  • Astrazeneca Plc
  • Eisai Co.
  • F. Hoffmann-La Roche Ag
  • Merck & Co., Inc.
  • Novartis International Ag
  • MORE

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Global Competitor Market Shares

Melanoma Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

TABLE 1: Melanoma Therapeutics Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 2: Melanoma Therapeutics Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017

TABLE 3: Melanoma Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025

TABLE 4: Cutaneous Melanoma (Type) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 5: Cutaneous Melanoma (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 6: Cutaneous Melanoma (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

TABLE 7: Ocular Melanoma (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025

TABLE 8: Ocular Melanoma (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017

TABLE 9: Ocular Melanoma (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025

TABLE 10: Mucosal Melanoma (Type) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025

TABLE 11: Mucosal Melanoma (Type) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017

TABLE 12: Mucosal Melanoma (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 13: Surgery (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025

TABLE 14: Surgery (Therapy) Market Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 15: Surgery (Therapy) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

TABLE 16: Immunotherapy (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 17: Immunotherapy (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 18: Immunotherapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 19: Targeted Therapy (Therapy) World Market Estimates and Forecasts in US$ Million by Region/Country: 2018 to 2025

TABLE 20: Targeted Therapy (Therapy) Market Worldwide Historic Review by Region/Country in US$ Million: 2009 to 2017

TABLE 21: Targeted Therapy (Therapy) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025

TABLE 22: Chemotherapy (Therapy) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2018 to 2025

TABLE 23: Chemotherapy (Therapy) Global Historic Demand in US$ Million by Region/Country: 2009 to 2017

TABLE 24: Chemotherapy (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

TABLE 25: Radiation Therapy (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025

TABLE 26: Radiation Therapy (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017

TABLE 27: Radiation Therapy (Therapy) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES

Market Facts & Figures

US Melanoma Therapeutics Market Share (in %) by Company: 2019 & 2025

TABLE 28: United States Melanoma Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 29: Melanoma Therapeutics Market in the United States by Type: A Historic Review in US$ Million for 2009-2017

TABLE 30: United States Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 31: United States Melanoma Therapeutics Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025

TABLE 32: Melanoma Therapeutics Market in the United States by Therapy: A Historic Review in US$ Million for 2009-2017

TABLE 33: United States Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

CANADA

TABLE 34: Canadian Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 35: Canadian Melanoma Therapeutics Historic Market Review by Type in US$ Million: 2009-2017

TABLE 36: Melanoma Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 37: Canadian Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025

TABLE 38: Canadian Melanoma Therapeutics Historic Market Review by Therapy in US$ Million: 2009-2017

TABLE 39: Melanoma Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

JAPAN

TABLE 40: Japanese Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 41: Melanoma Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 42: Japanese Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 43: Japanese Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025

TABLE 44: Melanoma Therapeutics Market in Japan: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017

TABLE 45: Japanese Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

CHINA

TABLE 46: Chinese Melanoma Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 47: Melanoma Therapeutics Historic Market Analysis in China in US$ Million by Type: 2009-2017

TABLE 48: Chinese Melanoma Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 49: Chinese Melanoma Therapeutics Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025

TABLE 50: Melanoma Therapeutics Historic Market Analysis in China in US$ Million by Therapy: 2009-2017

TABLE 51: Chinese Melanoma Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

EUROPE

Market Facts & Figures

European Melanoma Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025

TABLE 52: European Melanoma Therapeutics Market Demand Scenario in US$ Million by Region/Country: 2018-2025

TABLE 53: Melanoma Therapeutics Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017

TABLE 54: European Melanoma Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025

TABLE 55: European Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 56: Melanoma Therapeutics Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 57: European Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 58: European Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025

TABLE 59: Melanoma Therapeutics Market in Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017

TABLE 60: European Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

FRANCE

TABLE 61: Melanoma Therapeutics Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 62: French Melanoma Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 63: French Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 64: Melanoma Therapeutics Market in France by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 65: French Melanoma Therapeutics Historic Market Scenario in US$ Million by Therapy: 2009-2017

TABLE 66: French Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

GERMANY

TABLE 67: Melanoma Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 68: German Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 69: German Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 70: Melanoma Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 71: German Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 72: German Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

ITALY

TABLE 73: Italian Melanoma Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 74: Melanoma Therapeutics Historic Market Analysis in Italy in US$ Million by Type: 2009-2017

TABLE 75: Italian Melanoma Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 76: Italian Melanoma Therapeutics Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025

TABLE 77: Melanoma Therapeutics Historic Market Analysis in Italy in US$ Million by Therapy: 2009-2017

TABLE 78: Italian Melanoma Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED KINGDOM

TABLE 79: United Kingdom Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 80: Melanoma Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 81: United Kingdom Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 82: United Kingdom Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025

TABLE 83: Melanoma Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017

TABLE 84: United Kingdom Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

SPAIN

TABLE 85: Spanish Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 86: Spanish Melanoma Therapeutics Historic Market Review by Type in US$ Million: 2009-2017

TABLE 87: Melanoma Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 88: Spanish Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025

TABLE 89: Spanish Melanoma Therapeutics Historic Market Review by Therapy in US$ Million: 2009-2017

TABLE 90: Melanoma Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

RUSSIA

TABLE 91: Russian Melanoma Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 92: Melanoma Therapeutics Market in Russia by Type: A Historic Review in US$ Million for 2009-2017

TABLE 93: Russian Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 94: Russian Melanoma Therapeutics Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025

TABLE 95: Melanoma Therapeutics Market in Russia by Therapy: A Historic Review in US$ Million for 2009-2017

TABLE 96: Russian Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

REST OF EUROPE

TABLE 97: Rest of Europe Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 98: Melanoma Therapeutics Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 99: Rest of Europe Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 100: Rest of Europe Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025

TABLE 101: Melanoma Therapeutics Market in Rest of Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017

TABLE 102: Rest of Europe Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

ASIA-PACIFIC

TABLE 103: Asia-Pacific Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 104: Melanoma Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017

TABLE 105: Asia-Pacific Melanoma Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025

TABLE 106: Melanoma Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 107: Asia-Pacific Melanoma Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 108: Asia-Pacific Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 109: Melanoma Therapeutics Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 110: Asia-Pacific Melanoma Therapeutics Historic Market Scenario in US$ Million by Therapy: 2009-2017

TABLE 111: Asia-Pacific Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

AUSTRALIA

TABLE 112: Melanoma Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 113: Australian Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 114: Australian Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 115: Melanoma Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 116: Australian Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 117: Australian Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

INDIA

TABLE 118: Indian Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 119: Indian Melanoma Therapeutics Historic Market Review by Type in US$ Million: 2009-2017

TABLE 120: Melanoma Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 121: Indian Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025

TABLE 122: Indian Melanoma Therapeutics Historic Market Review by Therapy in US$ Million: 2009-2017

TABLE 123: Melanoma Therapeutics Market in India: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

SOUTH KOREA

TABLE 124: Melanoma Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 125: South Korean Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 126: Melanoma Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025

TABLE 127: Melanoma Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 128: South Korean Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 129: Melanoma Therapeutics Market Share Distribution in South Korea by Therapy: 2009 VS 2019 VS 2025

REST OF ASIA-PACIFIC

TABLE 130: Rest of Asia-Pacific Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 131: Melanoma Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 132: Rest of Asia-Pacific Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 133: Rest of Asia-Pacific Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025

TABLE 134: Melanoma Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017

TABLE 135: Rest of Asia-Pacific Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

LATIN AMERICA

TABLE 136: Latin American Melanoma Therapeutics Market Trends by Region/Country in US$ Million: 2018-2025

TABLE 137: Melanoma Therapeutics Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017

TABLE 138: Latin American Melanoma Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025

TABLE 139: Latin American Melanoma Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 140: Melanoma Therapeutics Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017

TABLE 141: Latin American Melanoma Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 142: Latin American Melanoma Therapeutics Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025

TABLE 143: Melanoma Therapeutics Historic Market Analysis in Latin America in US$ Million by Therapy: 2009-2017

TABLE 144: Latin American Melanoma Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

ARGENTINA

TABLE 145: Argentinean Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 146: Melanoma Therapeutics Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 147: Argentinean Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 148: Argentinean Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025

TABLE 149: Melanoma Therapeutics Market in Argentina in US$ Million by Therapy: A Historic Review for the Period 2009-2017

TABLE 150: Argentinean Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

BRAZIL

TABLE 151: Melanoma Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 152: Brazilian Melanoma Therapeutics Historic Market Scenario in US$ Million by Type: 2009-2017

TABLE 153: Brazilian Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 154: Melanoma Therapeutics Market in Brazil by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025

TABLE 155: Brazilian Melanoma Therapeutics Historic Market Scenario in US$ Million by Therapy: 2009-2017

TABLE 156: Brazilian Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

MEXICO

TABLE 157: Melanoma Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 158: Mexican Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 159: Mexican Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 160: Melanoma Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 161: Mexican Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 162: Mexican Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

REST OF LATIN AMERICA

TABLE 163: Rest of Latin America Melanoma Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 164: Melanoma Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017

TABLE 165: Rest of Latin America Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 166: Rest of Latin America Melanoma Therapeutics Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025

TABLE 167: Melanoma Therapeutics Market in Rest of Latin America by Therapy: A Historic Review in US$ Million for 2009-2017

TABLE 168: Rest of Latin America Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

MIDDLE EAST

TABLE 169: The Middle East Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025

TABLE 170: Melanoma Therapeutics Market in the Middle East by Region/Country in US$ Million: 2009-2017

TABLE 171: The Middle East Melanoma Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025

TABLE 172: The Middle East Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025

TABLE 173: The Middle East Melanoma Therapeutics Historic Market by Type in US$ Million: 2009-2017

TABLE 174: Melanoma Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025

TABLE 175: The Middle East Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025

TABLE 176: The Middle East Melanoma Therapeutics Historic Market by Therapy in US$ Million: 2009-2017

TABLE 177: Melanoma Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025

IRAN

TABLE 178: Iranian Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025

TABLE 179: Melanoma Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017

TABLE 180: Iranian Melanoma Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025

TABLE 181: Iranian Market for Melanoma Therapeutics: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025

TABLE 182: Melanoma Therapeutics Market in Iran: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017

TABLE 183: Iranian Melanoma Therapeutics Market Share Analysis by Therapy: 2009 VS 2019 VS 2025

ISRAEL

TABLE 184: Israeli Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Type: 2018-2025

TABLE 185: Melanoma Therapeutics Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017

TABLE 186: Israeli Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 187: Israeli Melanoma Therapeutics Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025

TABLE 188: Melanoma Therapeutics Market in Israel in US$ Million by Therapy: A Historic Review for the Period 2009-2017

TABLE 189: Israeli Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

SAUDI ARABIA

TABLE 190: Saudi Arabian Melanoma Therapeutics Market Growth Prospects in US$ Million by Type for the Period 2018-2025

TABLE 191: Melanoma Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017

TABLE 192: Saudi Arabian Melanoma Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025

TABLE 193: Saudi Arabian Melanoma Therapeutics Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025

TABLE 194: Melanoma Therapeutics Historic Market Analysis in Saudi Arabia in US$ Million by Therapy: 2009-2017

TABLE 195: Saudi Arabian Melanoma Therapeutics Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025

UNITED ARAB EMIRATES

TABLE 196: Melanoma Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 197: United Arab Emirates Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 198: Melanoma Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025

TABLE 199: Melanoma Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 200: United Arab Emirates Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 201: Melanoma Therapeutics Market Share Distribution in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025

REST OF MIDDLE EAST

TABLE 202: Melanoma Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025

TABLE 203: Rest of Middle East Melanoma Therapeutics Historic Market Analysis in US$ Million by Type: 2009-2017

TABLE 204: Rest of Middle East Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 205: Melanoma Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025

TABLE 206: Rest of Middle East Melanoma Therapeutics Historic Market Analysis in US$ Million by Therapy: 2009-2017

TABLE 207: Rest of Middle East Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

AFRICA

TABLE 208: African Melanoma Therapeutics Market Estimates and Projections in US$ Million by Type: 2018 to 2025

TABLE 209: Melanoma Therapeutics Market in Africa by Type: A Historic Review in US$ Million for 2009-2017

TABLE 210: African Melanoma Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025

TABLE 211: African Melanoma Therapeutics Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025

TABLE 212: Melanoma Therapeutics Market in Africa by Therapy: A Historic Review in US$ Million for 2009-2017

TABLE 213: African Melanoma Therapeutics Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

AMGEN

ASTRAZENECA PLC

BRISTOL-MYERS SQUIBB COMPANY

EISAI CO.

F. HOFFMANN-LA ROCHE AG

IOVANCE BIOTHERAPEUTICS, INC.

MERCK & CO., INC.

NOVARTIS INTERNATIONAL AG

PFIZER

V. CURATED RESEARCH

Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Amgen
  • Astrazeneca Plc
  • Bristol-Myers Squibb Company
  • Eisai Co.
  • F. Hoffmann-La Roche Ag
  • Iovance Biotherapeutics, Inc.
  • Merck & Co., Inc.
  • Novartis International Ag
  • Pfizer
Note: Product cover images may vary from those shown
Adroll
adroll